EP1514562A3
Hemofiltration system
Abstract
A multipurpose hemofiltration system (10) and method are disclosed for the removal of fluid and/or soluble waste from the blood of a patient. The system (10) continuously monitors the flow rates of drained fluid, blood, and infusate. When necessary, the pumping rates of the infusate, drained fluid and blood are adjusted to remove a preselected amount of fluid from the blood in a preselected time period. A supervisory controller (160) can monitor patient parameters, such as heart rate (120) and blood pressure (130), and adjust the pumping rates accordingly. The supervisory controller (160) uses fuzzy logic to make expert decisions, based upon a set of supervisory rules, to control each pumping rate to achieve a desired flow rate and to respond to fault conditions. An adaptive controller (162) corrects temporal variations in the flow rate based upon an adaptive law and a control law.
Term
Term ended
Projected expiry passed 28 April 2020, 6.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both waysCites: the store holds 5 of 6
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP0300201A1 | Cites | European Patent Office (EPO) | AD | Search report | 1,6,7 |
| EP0611228A2 | Cites | European Patent Office (EPO) | A | Search report | 1,6,7 |
| US5503624A | Cites | United States of America | A | Search report | 1,6,7 |
| WO9306875A1 | Cites | World Intellectual Property Organization (WIPO) | AD | Search report | 1,6,7 |
| WO9850091A1 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1,6,7 |
28 members in 10 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 131955P | United States of America | – | |
| 13195599 | United States of America | P | |
| 13195599 | United States of America | P | |
| 00928598 | European Patent Office (EPO) | A | |
| 00928598 | European Patent Office (EPO) | A | |
| 00928598 | – | – | – |
| 131955P | – | – | – |
| EP20000928598 | – | – | – |
| US19990131955P | – | – | – |
Members28
| Document | Office | Kind | |
|---|---|---|---|
| CA2368809A1 | Canada | A1 | |
| WO0066197A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4681100A | Australia | A | |
| BR0009799A | Brazil | A | |
| EP1175238A1 | European Patent Office (EPO) | A1 | |
| IL145897D0 | Israel | D0 | |
| JP2002542900A | Japan | A | |
| AU766427B2 | Australia | B2 | |
| US6780322B1 | United States of America | B1 | |
| EP1514562A2 | European Patent Office (EPO) | A2 | |
| US2005126961A1 | United States of America | A1 | |
| EP1514562A3This record | European Patent Office (EPO) | A3 | |
| CA2368809C | Canada | C | |
| EP1175238B1 | European Patent Office (EPO) | B1 | |
| AT316391T | Austria | T | |
| ATE316391T1 | Austria | T1 | |
| DE60025716D1 | Germany | D1 | |
| DE60025716T2 | Germany | T2 | |
| IL145897A | Israel | A | |
| BR0009799B1 | Brazil | B1 | |
| EP1514562B1 | European Patent Office (EPO) | B1 | |
| AT429259T | Austria | T | |
| ATE429259T1 | Austria | T1 | |
| DE60042088D1 | Germany | D1 | |
| US2010038317A1 | United States of America | A1 | |
| US7857976B2 | United States of America | B2 | |
| JP2011147803A | Japan | A | |
| JP4903311B2 | Japan | B2 |
59 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Patent ceasedCeasedPL | PL | CH | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Change of address of patent owner(s)CHILDREN'S HOSPITAL MEDICAL CENTER;3333 BURNET AVENUE;CINCINNATI, OH 45229-3039 (US)PCOW | PCOW | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| New agentNV | NV | CH | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAKX | AKX | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1514562
- Publication, DOCDB
- 1514562
- Publication, EPODOC
- EP1514562
- Application
- 4078443
- Application, DOCDB
- 04078443
- Application, EPODOC
- EP20040078443
Titles3
- German
- Hämofiltrationssystem
- English
- Hemofiltration system
- French
- Système d'hémofiltration
Classification
- CPC, 26
- G05B13/0275
- A61M1/16
- A61M1/34
- A61M1/1603
- A61M1/342
- A61M1/1605
- A61M1/3496
- A61M1/1611
- A61M2205/3331
- A61M1/1615
- A61M2205/3393
- A61M1/1643
- A61M2205/50
- A61M1/1647
- Y10S210/929
- A61M1/341
- A61M1/3413
- A61M1/3434
- A61M1/3437
- A61M1/3451
- A61M1/3441
- A61M1/3607
- A61M1/3639
- A61M2205/3334
- A61M2205/3344
- A61M1/3623
- IPC, 7
- A61M1 14
- A61M1 16
- A61M1 34
- B01D61 14
- B01D61 22
- B01D61 32
- G05B13 02
Designated states19
- Contracting states, 19
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden